Infecciones en cirugía de artroplastía de cadera: Resultados del sistema de vigilancias epidemiológica de las infecciones intrahospitalarias. 1996-1999

Abstract

Epidemiological surveillance of nosocomial infections in hip arthroplasty was established in chilean hospitals in 1996. Between 1996 and 1999 the surveillance system reported, in 28 hospitals, 134 infections in 3.889 operations, with a cummulative rate of 3.5%. Epidemiological surveillance in Chile does not differentiate infections of the surgical wound from infections of the hip replacement itself, and the period of follow up is during hospital stay after surgery. The most frequent etiological agents were non fermentative Gram negative bacilli (33.3%), mainly Acinetobacter baumannii. Gram positive cocci represented 23.8% of the etiologies. Hospitals with higher mean number of operations had lower rates (5.0% in hospitals with low surgical volume and 2.9% in hospitals with higher volume). The findings of the surveillance system suggest some risk factors that require further research, such as the duration of preoperative hospital stay and experience of the surgical center.

Comparative of Infection Rate in Non-Elective and Elective Surgery, and Its Relation on Quality of Life

“…This infection prevalence figure is similar to those reported by other studies and what the EPINE considered "within normal limits". Currently, hip arthroplasty infection rate are around 1.5% [22][23][24][25][26][27], being published rates range between 0.86% and 4.8%. In a study conducted in a secondary level hospital of Lleida (Hospital Universitario de Arnau de Vilanova) between 1994 and 2003, the hip replacement infection rate was 1.2% [8].…”

Perfil Epidemiológico de las Infecciones Intrahospitalarias en la Clínica Centenario Peruano Japonesa durante el 201

“…Además se constituye en un reto mundial en busca de la seguridad de los pacientes (2) . En Chile se notifican alrededor de 70.000 Infecciones intrahospitalarias anuales y se estima que cada de ellas prolonga en promedio 10 días la estadía hospitalaria lo cual significaría 700.000 días cama utilizados en Infecciones intrahospitalarias asociado a un costo para el país de US$ 70.000.000 aproximadamente (3,4) .…”